FDA Orange Book · active-ingredient family
Hydroxocobalamin
Hydroxocobalamin is approved as 1 brand and 5 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:CYANOKIT · NDA 022041
1
Brand (NDA)
5
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CYANOKITRLD×2 | BTG INTL | NDA 022041 | — | Apr 08, 2011 |
Generic (ANDA) products (5)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ALPHAREDISOL | MERCK | ANDA 080778 | — | Approved Prior to Jan 1, 1982 | |
| HYDROXOCOBALAMIN | ABRAXIS PHARM | ANDA 084921 | — | Approved Prior to Jan 1, 1982 | |
| HYDROXOCOBALAMIN | ACTAVIS | ANDA 085998 | — | Approved Prior to Jan 1, 1982 | |
| HYDROXOCOBALAMIN | WATSON LABS | ANDA 085528 | — | Approved Prior to Jan 1, 1982 | |
| HYDROXOMIN | BEL MAR | ANDA 084629 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Hydroxocobalamin — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

